Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Other Operating Expenses (2017 - 2025)

Selectis Health's Other Operating Expenses history spans 14 years, with the latest figure at $8.6 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 2.47% year-over-year to $8.6 million; the TTM value through Sep 2025 reached $33.3 million, up 1.47%, while the annual FY2024 figure was $33.0 million, 3.34% down from the prior year.
  • Other Operating Expenses for Q3 2025 was $8.6 million at Selectis Health, up from $8.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $9.7 million in Q4 2021 and bottomed at $2.2 million in Q1 2021.
  • The 5-year median for Other Operating Expenses is $8.0 million (2023), against an average of $7.3 million.
  • The largest annual shift saw Other Operating Expenses soared 643.86% in 2021 before it plummeted 55.11% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $9.7 million in 2021, then dropped by 4.95% to $9.2 million in 2022, then rose by 0.66% to $9.3 million in 2023, then fell by 11.6% to $8.2 million in 2024, then grew by 4.83% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Other Operating Expenses are $8.6 million (Q3 2025), $8.3 million (Q2 2025), and $8.2 million (Q1 2025).